BrightSpring Health Services, Inc.
BTSGNasdaqCIK 1865782HealthcareFiscal year ends Dec 31
Reports and events: 63 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-3008:45 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001865782-26-000012 |
| 2026-10-3006:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001865782-26-000011 |
| 2026-07-3108:45 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-327014 |
| 2026-07-3106:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-326654 |
| 2026-06-1216:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-269360 |
| 2026-06-0517:21 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001140361-26-024308 |
| 2026-06-0516:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-259531 |
| 2026-05-2116:15 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-234435 |
| 2026-05-0108:45 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-199339 |
| 2026-05-0106:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-198983 |
| 2026-04-1016:00 ET | DEF 14A | Proxy statementPeriod 2026-04-10 | 0001193125-26-151207 |
| 2026-03-3107:40 ET | 8-K | 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-133307 |
| 2026-03-0419:37 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001140361-26-007942 |
| 2026-03-0416:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001865782-26-000008 |
| 2026-02-2708:46 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-079454 |
| 2026-02-2706:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-078998 |
| 2025-10-2816:35 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-253631 |
| 2025-10-2816:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-253503 |
| 2025-10-2217:12 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001140361-25-038959 |
| 2025-10-2216:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-246752 |
| 2025-10-2016:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-243598 |
| 2025-08-0108:46 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-101119 |
| 2025-08-0106:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-101093 |
| 2025-06-2616:31 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001140361-25-023832 |
| 2025-06-2017:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-088587 |
| 2025-06-1219:35 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001140361-25-022342 |
| 2025-06-1216:19 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-25-085363 |
| 2025-06-1016:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-084281 |
| 2025-06-0317:15 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-081109 |
| 2025-05-0208:00 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-062263 |
| 2025-05-0206:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-062245 |
| 2025-04-1816:32 ET | DEF 14A | Proxy statementPeriod 2025-05-28 | 0000950170-25-055886 |
| 2025-04-1517:15 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-054320 |
| 2025-03-0608:40 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-034196 |
| 2025-03-0606:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-034152 |
| 2025-03-0517:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-033847 |
| 2025-01-2106:03 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-006965 |
| 2024-12-1116:10 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-135375 |
| 2024-11-1517:20 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-127696 |
| 2024-11-0108:55 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-119820 |
| 2024-11-0106:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-119790 |
| 2024-10-1117:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-114404 |
| 2024-09-3007:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-110168 |
| 2024-09-1818:24 ET | SC 13D | Ownership report, active investor | 0001140361-24-041401 |
| 2024-08-0208:50 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-089623 |
| 2024-08-0206:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-089576 |
| 2024-06-2416:35 ET | 8-K | 3.02 Unregistered sale of equity | 0000950170-24-076783 |
| 2024-05-3116:38 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-067369 |
| 2024-05-0208:55 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-051607 |
| 2024-05-0206:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-051549 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 31, 2026, 15:25 ET. Listed shows no prices and gives no investment advice.